Page last updated: 2024-08-23

cromolyn sodium and leukotriene e4

cromolyn sodium has been researched along with leukotriene e4 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Felsien, D; Larsen, GL; Smith, HR; Thomas, RB; Voelkel, NF; Wenzel, SE; Westcott, JY1
Amayasu, H; Nakagawa, H; Onuma, K; Sakamoto, H; Shoji, T; Tajima, T; Yoshida, S1
Akahori, K; Amayasu, H; Hasegawa, H; Nakabayashi, M; Nakagawa, H; Sakamoto, H; Sakamoto, M; Shoji, T; Tajimab, T; Yamawaki, Y; Yoshida, S1
Anderson, SD; Brannan, JD; Dahlén, B; Dahlén, SE; Kippelen, P; Larsson, J1
Chen, M; Christiansen, S; Doherty, TA; Kim, A; Zuraw, B1
Butterfield, J; Castells, M1

Reviews

1 review(s) available for cromolyn sodium and leukotriene e4

ArticleYear
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
    The journal of allergy and clinical immunology. In practice, 2019, Volume: 7, Issue:4

    Topics: Anti-Allergic Agents; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cromolyn Sodium; Disease Management; Glucocorticoids; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Hydroxyurea; Interleukin-6; Leukotriene Antagonists; Leukotriene E4; Mastocytosis; Omalizumab; Prostaglandin D2; Tryptases

2019

Trials

3 trial(s) available for cromolyn sodium and leukotriene e4

ArticleYear
Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1998, Volume: 80, Issue:2

    Topics: Administration, Inhalation; Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchi; Bronchoconstriction; Creatinine; Cromolyn Sodium; Dipyrone; Female; Forced Expiratory Volume; Humans; Leukotriene E4; Male; Middle Aged; Respiratory Function Tests; Vital Capacity

1998
Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma.
    International archives of allergy and immunology, 1998, Volume: 117, Issue:2

    Topics: Adult; Anti-Asthmatic Agents; Aspirin; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstriction; Chromatography, High Pressure Liquid; Cromolyn Sodium; Cross-Over Studies; Dipyrone; Double-Blind Method; Female; Humans; Leukotriene E4; Male; Methacholine Chloride; Middle Aged

1998
Effect of sodium cromoglycate on mast cell mediators during hyperpnea in athletes.
    Medicine and science in sports and exercise, 2010, Volume: 42, Issue:10

    Topics: Adrenergic Agonists; Adult; Androstadienes; Asthma, Exercise-Induced; Athletes; Bronchodilator Agents; Cromolyn Sodium; Dinoprost; Exercise Test; Female; Fluticasone; Forced Expiratory Volume; Humans; Hyperventilation; Inflammation Mediators; Leukotriene E4; Male; Mast Cells; Young Adult

2010

Other Studies

2 other study(ies) available for cromolyn sodium and leukotriene e4

ArticleYear
Urinary leukotriene E4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate.
    The American review of respiratory disease, 1991, Volume: 143, Issue:6

    Topics: Adult; Asthma; Cromolyn Sodium; Forced Expiratory Volume; Humans; Leukotriene E4; Lung; Methacholine Chloride; Middle Aged; Peak Expiratory Flow Rate; Respiratory System; SRS-A; Time Factors

1991
Mast cell disorders: Protean manifestations and treatment responses.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018, Volume: 121, Issue:1

    Topics: Abdominal Pain; Adult; Anaphylaxis; Angioedema; Anti-Asthmatic Agents; Biomarkers; Cromolyn Sodium; Diarrhea; Dinoprost; Female; Histamine Antagonists; Humans; Leukotriene E4; Male; Mast Cells; Mastocytosis; Middle Aged; Omalizumab; Prostaglandin D2; Treatment Outcome; Tryptases; Urticaria

2018